Plasma Haptoglobin Concentrations Are Elevated in Patients with Coronary Artery Disease

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Lee, Chin Wei ^a   Cheng, Tsai Mu ^b   Lin, Chih Pei ^a,c   Pan, Ju Pin ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYACRYLAMIDE GEL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; HEART EJECTION FRACTION; HEART VENTRICLE WALL MOTION; HUMAN; HYPERTENSION; LUMINAL STENOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PHENOTYPE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX RATIO; STENOSIS;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HAPTOGLOBINS; HUMANS; MALE; PHENOTYPE; ROC CURVE;

EID: 84885168351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076817     Document Type: Article

References (30)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation127: 143-152. doi:10.1161/CIR.0b013e318282ab8f. PubMed: 23283859.
2. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695. doi:10.1056/NEJMra043430. PubMed: 15843671.
3. Wilson PW, (2008) Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med 121: S15-S20. doi:10.1016/j.amjmed.2008.01.031. PubMed: 18926165.
4. McPherson R, Davies RW, (2012) Inflammation and coronary artery disease: insights from genetic studies. Can J Cardiol 28: 662-666. doi:10.1016/j.cjca.2012.05.014. PubMed: 22902153.
5. Morimatsu M, Syuto B, Shimada N, Fujinaga T, Yamamoto S, et al. (1991) Isolation and characterization of bovine haptoglobin from acute phase sera. J Biol Chem 266: 11833-11837. PubMed: 1904872.
6. Bowman BH, Kurosky A, (1982) Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 12: 189-454. 6751044.
7. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, et al. (2001) Identification of the haemoglobin scavenger receptor. Nature 409: 198-201. doi:10.1038/35051594. PubMed: 11196644.
8. Tseng CF, Lin CC, Huang HY, Liu HC, Mao SJ, (2004) Antioxidant role of human haptoglobin. Proteomics 4: 2221-2228. doi:10.1002/pmic.200300787. PubMed: 15274115.
9. Langlois MR, Delanghe JR, (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600. PubMed: 8855140.
10. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, et al. (2001) Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98: 3693-3698. doi:10.1182/blood.V98.13.3693. PubMed: 11739174.
11. Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, et al. (2007) Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 27: 134-140. doi:10.1161/01.ATV.0000251020.24399.a2. PubMed: 17068284.
12. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G, (2009) Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Ann Med 41: 522-532. doi:10.1080/07853890903089453. PubMed: 19657769.
13. Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, et al. (2002) Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J Am Coll Cardiol 40: 1984-1990. doi:10.1016/S0735-1097(02)02534-2. PubMed: 12475459.
14. Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, et al. (2003) Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Diabetes Care 26: 2628-2631. doi:10.2337/diacare.26.9.2628. PubMed: 12941730.
15. Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, et al. (2005) Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 54: 2802-2806. doi:10.2337/diabetes.54.9.2802. PubMed: 16123372.
16. Levy AP, Larson MG, Corey D, Lotan R, Vita JA, et al. (2004) Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort. Atherosclerosis 172: 361-365. doi:10.1016/j.atherosclerosis.2003.10.014. PubMed: 15019547.
17. Liau CY, Chang TM, Pan JP, Chen WL, Mao SJ, (2003) Purification of human plasma haptoglobin by hemoglobin-affinity column chromatography. J Chromatogr B Anal Technol Biomed Life Sci 790: 209-216. doi:10.1016/S1570-0232(03)00128-4. PubMed: 12767333.
18. Tseng CF, Huang HY, Yang YT, Mao SJ, (2004) Purification of human haptoglobin 1-1, 2-1, and 2-2 using monoclonal antibody affinity chromatography. Protein Expr Purif 33: 265-273. doi:10.1016/j.pep.2003.09.006. PubMed: 14711515.
19. Pan JP, Cheng TM, Shih CC, Chiang SC, Chou SC, et al. (2011) Haptoglobin phenotypes and plasma haptoglobin levels in patients with abdominal aortic aneurysm. J Vasc Surg 53: 1189-1194. doi:10.1016/j.jvs.2010.10.122. PubMed: 21296538.
20. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, et al. (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51: 5-40. doi:10.1161/01.CIR.51.4.5. PubMed: 1116248.
21. Cheng TM, Pan JP, Lai ST, Kao LP, Lin HH, et al. (2007) Immunochemical property of human haptoglobin phenotypes: determination of plasma haptoglobin using type-matched standards. Clin Biochem 40: 1045-1056. doi:10.1016/j.clinbiochem.2007.04.018. PubMed: 17583688.
22. Carter K, Worwood M, (2007) Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 29: 92-110. doi:10.1111/j.1751-553X.2007.00898.x. PubMed: 17474882.
23. Aristoteli LP, Møller HJ, Bailey B, Moestrup SK, Kritharides L, (2006) The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis 184: 342-347. doi:10.1016/j.atherosclerosis.2005.05.004. PubMed: 15979079.
24. Delanghe JR, Langlois MR, De Buyzere ML, (2011) Haptoglobin polymorphism: a key factor in the proatherogenic role of B cells? Atherosclerosis 217: 80-82. doi:10.1016/j.atherosclerosis.2011.03.031. PubMed: 21507405.
25. Hamirani YS, Pandey S, Rivera JJ, Ndumele C, Budoff MJ, et al. (2008) Markers of inflammation and coronary artery calcification: a systematic review. Atherosclerosis 201: 1-7. doi:10.1016/j.atherosclerosis.2008.04.045. PubMed: 18561934.
26. Moreno PR, Purushothaman KR, Purushothaman M, Muntner P, Levy NS, et al. (2008) Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque. J Am Coll Cardiol 52: 1049-1051. doi:10.1016/j.jacc.2008.06.029. PubMed: 18848136.
27. Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D, (1999) Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145: 287-292. doi:10.1016/S0021-9150(99)00079-9. PubMed: 10488955.
28. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, et al. (2000) Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 343: 969-970. doi:10.1056/NEJM200009283431313. PubMed: 11012324.
29. Staals J, Pieters BM, Knottnerus IL, Rouhl RP, van Oostenbrugge RJ, et al. (2008) Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res 5: 153-158. doi:10.2174/156720208785425675. PubMed: 18691072.
30. De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H, et al. (2001) Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 157: 161-166. doi:10.1016/S0021-9150(00)00690-0. PubMed: 11427216.